daniel wallace

Professor of Medicine

Cedars-Sinai Medical Center

United States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Collaborators (3)

Sasha Bernatsky

McGill University Health Centre

Caroline Gordon

University of Birmingham

UNITED KINGDOM

Sang‐Cheol Bae

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

daniel wallace

Research Interests

Explore related searches

Contact this professor

Articles (10)

Collaborators (3)

Sasha Bernatsky

Caroline Gordon

Sang‐Cheol Bae

Make your next move.

daniel wallace

Research Interests

Explore related searches

Contact this professor

Articles (10)

Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling

Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Evobrutinib in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Dose‐Ranging Trial

Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic

Progress toward Better Treatment of Lupus

Suggested additions to future directions: comment on the ACR white paper on antimalarials and cardiac toxicity by Desmarais et al

Safety and clinical activity of atacicept in the long-term extension of the phase 2b ADDRESS II study in systemic lupus erythematosus

Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE)

A Multianalyte Assay Panel With Cell‐Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology–Classified Lupus

Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways

Collaborators (3)

Sasha Bernatsky

Caroline Gordon

Sang‐Cheol Bae

Make your next move.